(Q40299700)

19 September 2017

Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization (English)

1 reference

19 September 2017

1 reference

8

Jeffery W Kelly

1 reference

19 September 2017

Daryl A Bosco

1

1 reference

19 September 2017

Douglas M Fowler

2

1 reference

19 September 2017

Qinghai Zhang

3

1 reference

19 September 2017

Jorge Nieva

4

1 reference

19 September 2017

Evan T Powers

5

1 reference

19 September 2017

Paul Wentworth

6

1 reference

19 September 2017

Richard A Lerner

7

1 reference

19 September 2017

26 March 2006

1 reference

19 September 2017

Nature Chemical Biology

1 reference

19 September 2017

2

1 reference

19 September 2017

249-253

1 reference

19 September 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1038/nchembio782

19 September 2017

0 references

cites work

alpha-Synuclein locus triplication causes Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO782

7 January 2021

The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO782

7 January 2021

Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO782

7 January 2021

Tissue transglutaminase is not involved in the aggregate formation of stably expressed alpha-synuclein in SH-SY5Y human neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO782

7 January 2021

Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO782

7 January 2021

Lipid rafts mediate the synaptic localization of alpha-synuclein.

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO782

7 January 2021

Evidence for Ozone Formation in Human Atherosclerotic Arteries

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO782

7 January 2021

Metabolite-initiated protein misfolding may trigger Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO782

7 January 2021

Oxidative metabolites accelerate Alzheimer's amyloidogenesis by a two-step mechanism, eliminating the requirement for nucleation

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO782

7 January 2021

Dementia with Lewy bodies: a review

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO782

7 January 2021

Human alpha-synuclein over-expression increases intracellular reactive oxygen species levels and susceptibility to dopamine.

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO782

7 January 2021

Effect of the overexpression of wild-type or mutant alpha-synuclein on cell susceptibility to insult

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO782

7 January 2021

Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO782

7 January 2021

Rapid Anionic Micelle-mediated α-Synuclein Fibrillization in Vitro

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO782

7 January 2021

alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO782

7 January 2021

Identifiers

DOI

10.1038/NCHEMBIO782

1 reference

Dimensions Publication ID

19 September 2017

0 references

1 reference